Polycythemia Vera Responds to Imatinib Mesylate
- 1 March 2003
- journal article
- case report
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 325 (3) , 149-152
- https://doi.org/10.1097/00000441-200303000-00007
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Defective expression of the SHP-1 phosphatase in polycythemia veraExperimental Hematology, 1999
- Polycythemia Vera V. Enhanced Proliferation and Phosphorylation Due to Vanadate Are Diminished in Polycythemia Vera Erythroid Progenitor Cells: A Possible Defect of Phosphatase Activity in Polycythemia VeraBlood, 1997
- Polycythaemia vera. IV. Specific binding of stem cell factor to normal and polycythaemia vera highly purified erythroid progenitor cellsBritish Journal of Haematology, 1994
- Polycythaemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expressionBritish Journal of Haematology, 1994
- Role of the KIT protooncogene in normal and malignant human hematopoiesis.Proceedings of the National Academy of Sciences, 1992
- POLYCYTHEMIA VERA AND LEUKEMIA—THE ROLE OF RADIATION TREATMENTMedicine, 1965